カテゴリー： LP Information, 世界, 部品/材料

世界の低用量水和物阻害剤（LDHI）市場予測 2023年-2029年

◆英語タイトル：Global Low Dosage Hydrate Inhibitors (LDHI) Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU5921）◆商品コード：LP23JU5921
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月（※2025年版があります。お問い合わせください。）
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の低用量水和物阻害剤（LDHI）市場」は、過去の販売実績から2022年の世界の低用量水和物阻害剤（LDHI）の総販売量を検討し、2023年から2029年の予測される低用量水和物阻害剤（LDHI）の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の低用量水和物阻害剤（LDHI）の市場規模を掲載し、XXX百万米ドル規模の世界の低用量水和物阻害剤（LDHI）市場の詳細な分析を提供します。本インサイトレポートは、世界の低用量水和物阻害剤（LDHI）業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の低用量水和物阻害剤（LDHI）市場における各社の独自のポジションをより深く理解するために、低用量水和物阻害剤（LDHI）製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の低用量水和物阻害剤（LDHI）市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。低用量水和物阻害剤（LDHI）の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。低用量水和物阻害剤（LDHI）の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。低用量水和物阻害剤（LDHI）のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

低用量水和物阻害剤（LDHI）の世界主要メーカーとしては、BASF、 Schlumberger、 Arkema、 Ashland、 ERO CHEM LLC、 Halliburton、 GE(Baker Hughes)、 Clariant Chemicals、 Ecolab、 GasHydrate LLCなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の低用量水和物阻害剤（LDHI）市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では低用量水和物阻害剤（LDHI）市場をセグメンテーションし、種類別 (抗凝集剤（AA）、運動性水和剤（KHI）、その他)、用途別 (オンショア、オフショア)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：抗凝集剤（AA）、運動性水和剤（KHI）、その他

・用途別区分：オンショア、オフショア

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の低用量水和物阻害剤（LDHI）市場の10年間の市場状況・展望は？
・世界および地域別に見た低用量水和物阻害剤（LDHI）市場成長の要因は何か？
・低用量水和物阻害剤（LDHI）の市場機会はエンドマーケットの規模によってどのように変化するのか？
・低用量水和物阻害剤（LDHI）のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：低用量水和物阻害剤（LDHI）の年間販売量2018-2029、地域別現状・将来分析
・低用量水和物阻害剤（LDHI）の種類別セグメント：抗凝集剤（AA）、運動性水和剤（KHI）、その他
・低用量水和物阻害剤（LDHI）の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・低用量水和物阻害剤（LDHI）の用途別セグメント：オンショア、オフショア
・低用量水和物阻害剤（LDHI）の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の低用量水和物阻害剤（LDHI）市場
・企業別のグローバル低用量水和物阻害剤（LDHI）市場データ：2018-2023年の年間販売量、市場シェア
・企業別の低用量水和物阻害剤（LDHI）の年間売上：2018-2023年の売上、市場シェア
・企業別の低用量水和物阻害剤（LDHI）販売価格
・主要企業の低用量水和物阻害剤（LDHI）生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

低用量水和物阻害剤（LDHI）の地域別レビュー
・地域別の低用量水和物阻害剤（LDHI）市場規模2018-2023：年間販売量、売上
・主要国別の低用量水和物阻害剤（LDHI）市場規模2018-2023：年間販売量、売上
・南北アメリカの低用量水和物阻害剤（LDHI）販売の成長
・アジア太平洋の低用量水和物阻害剤（LDHI）販売の成長
・ヨーロッパの低用量水和物阻害剤（LDHI）販売の成長
・中東・アフリカの低用量水和物阻害剤（LDHI）販売の成長

南北アメリカ市場
・南北アメリカの国別の低用量水和物阻害剤（LDHI）販売量、売上（2018-2023）
・南北アメリカの低用量水和物阻害剤（LDHI）の種類別販売量
・南北アメリカの低用量水和物阻害剤（LDHI）の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の低用量水和物阻害剤（LDHI）販売量、売上（2018-2023）
・アジア太平洋の低用量水和物阻害剤（LDHI）の種類別販売量
・アジア太平洋の低用量水和物阻害剤（LDHI）の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の低用量水和物阻害剤（LDHI）販売量、売上（2018-2023）
・ヨーロッパの低用量水和物阻害剤（LDHI）の種類別販売量
・ヨーロッパの低用量水和物阻害剤（LDHI）の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の低用量水和物阻害剤（LDHI）販売量、売上（2018-2023）
・中東・アフリカの低用量水和物阻害剤（LDHI）の種類別販売量
・中東・アフリカの低用量水和物阻害剤（LDHI）の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・低用量水和物阻害剤（LDHI）の製造コスト構造分析
・低用量水和物阻害剤（LDHI）の製造プロセス分析
・低用量水和物阻害剤（LDHI）の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・低用量水和物阻害剤（LDHI）の主要なグローバル販売業者
・低用量水和物阻害剤（LDHI）の主要なグローバル顧客

地域別の低用量水和物阻害剤（LDHI）市場予測レビュー
・地域別の低用量水和物阻害剤（LDHI）市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・低用量水和物阻害剤（LDHI）の種類別市場規模予測
・低用量水和物阻害剤（LDHI）の用途別市場規模予測

主要企業分析
BASF、 Schlumberger、 Arkema、 Ashland、 ERO CHEM LLC、 Halliburton、 GE(Baker Hughes)、 Clariant Chemicals、 Ecolab、 GasHydrate LLC
・企業情報
・低用量水和物阻害剤（LDHI）製品
・低用量水和物阻害剤（LDHI）販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Hydrate inhibitors are the chemical substances designed to control the formation of hydrates during natural gas production at an oil or gas condensate well. Hydrate inhibitors help avoid problems due to hydrate formation such as hydrate plugs and line blockages.
LPI (LP Information)’ newest research report, the “Low Dosage Hydrate Inhibitors (LDHI) Industry Forecast” looks at past sales and reviews total world Low Dosage Hydrate Inhibitors (LDHI) sales in 2022, providing a comprehensive analysis by region and market sector of projected Low Dosage Hydrate Inhibitors (LDHI) sales for 2023 through 2029. With Low Dosage Hydrate Inhibitors (LDHI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Low Dosage Hydrate Inhibitors (LDHI) industry.
This Insight Report provides a comprehensive analysis of the global Low Dosage Hydrate Inhibitors (LDHI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Low Dosage Hydrate Inhibitors (LDHI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Low Dosage Hydrate Inhibitors (LDHI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Low Dosage Hydrate Inhibitors (LDHI) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Low Dosage Hydrate Inhibitors (LDHI).
The global Low Dosage Hydrate Inhibitors (LDHI) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Low Dosage Hydrate Inhibitors (LDHI) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Low Dosage Hydrate Inhibitors (LDHI) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Low Dosage Hydrate Inhibitors (LDHI) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Low Dosage Hydrate Inhibitors (LDHI) players cover BASF, Schlumberger, Arkema, Ashland, ERO CHEM LLC, Halliburton, GE(Baker Hughes), Clariant Chemicals and Ecolab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Low Dosage Hydrate Inhibitors (LDHI) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Anti-Agglomerate (AA) Inhibitors
Kinetic Hydrate Inhibitors (KHI)
Others
Segmentation by application
Onshore
Offshore
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BASF
Schlumberger
Arkema
Ashland
ERO CHEM LLC
Halliburton
GE(Baker Hughes)
Clariant Chemicals
Ecolab
GasHydrate LLC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Low Dosage Hydrate Inhibitors (LDHI) market?
What factors are driving Low Dosage Hydrate Inhibitors (LDHI) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Low Dosage Hydrate Inhibitors (LDHI) market opportunities vary by end market size?
How does Low Dosage Hydrate Inhibitors (LDHI) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Low Dosage Hydrate Inhibitors (LDHI) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Low Dosage Hydrate Inhibitors (LDHI) by Country/Region, 2018, 2022 & 2029
2.2 Low Dosage Hydrate Inhibitors (LDHI) Segment by Type
2.2.1 Anti-Agglomerate (AA) Inhibitors
2.2.2 Kinetic Hydrate Inhibitors (KHI)
2.2.3 Others
2.3 Low Dosage Hydrate Inhibitors (LDHI) Sales by Type
2.3.1 Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Type (2018-2023)
2.3.2 Global Low Dosage Hydrate Inhibitors (LDHI) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Low Dosage Hydrate Inhibitors (LDHI) Sale Price by Type (2018-2023)
2.4 Low Dosage Hydrate Inhibitors (LDHI) Segment by Application
2.4.1 Onshore
2.4.2 Offshore
2.5 Low Dosage Hydrate Inhibitors (LDHI) Sales by Application
2.5.1 Global Low Dosage Hydrate Inhibitors (LDHI) Sale Market Share by Application (2018-2023)
2.5.2 Global Low Dosage Hydrate Inhibitors (LDHI) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Low Dosage Hydrate Inhibitors (LDHI) Sale Price by Application (2018-2023)
3 Global Low Dosage Hydrate Inhibitors (LDHI) by Company
3.1 Global Low Dosage Hydrate Inhibitors (LDHI) Breakdown Data by Company
3.1.1 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Sales by Company (2018-2023)
3.1.2 Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Company (2018-2023)
3.2 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Revenue by Company (2018-2023)
3.2.1 Global Low Dosage Hydrate Inhibitors (LDHI) Revenue by Company (2018-2023)
3.2.2 Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Company (2018-2023)
3.3 Global Low Dosage Hydrate Inhibitors (LDHI) Sale Price by Company
3.4 Key Manufacturers Low Dosage Hydrate Inhibitors (LDHI) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Low Dosage Hydrate Inhibitors (LDHI) Product Location Distribution
3.4.2 Players Low Dosage Hydrate Inhibitors (LDHI) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Low Dosage Hydrate Inhibitors (LDHI) by Geographic Region
4.1 World Historic Low Dosage Hydrate Inhibitors (LDHI) Market Size by Geographic Region (2018-2023)
4.1.1 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Low Dosage Hydrate Inhibitors (LDHI) Market Size by Country/Region (2018-2023)
4.2.1 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Low Dosage Hydrate Inhibitors (LDHI) Sales Growth
4.4 APAC Low Dosage Hydrate Inhibitors (LDHI) Sales Growth
4.5 Europe Low Dosage Hydrate Inhibitors (LDHI) Sales Growth
4.6 Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales Growth
5 Americas
5.1 Americas Low Dosage Hydrate Inhibitors (LDHI) Sales by Country
5.1.1 Americas Low Dosage Hydrate Inhibitors (LDHI) Sales by Country (2018-2023)
5.1.2 Americas Low Dosage Hydrate Inhibitors (LDHI) Revenue by Country (2018-2023)
5.2 Americas Low Dosage Hydrate Inhibitors (LDHI) Sales by Type
5.3 Americas Low Dosage Hydrate Inhibitors (LDHI) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Low Dosage Hydrate Inhibitors (LDHI) Sales by Region
6.1.1 APAC Low Dosage Hydrate Inhibitors (LDHI) Sales by Region (2018-2023)
6.1.2 APAC Low Dosage Hydrate Inhibitors (LDHI) Revenue by Region (2018-2023)
6.2 APAC Low Dosage Hydrate Inhibitors (LDHI) Sales by Type
6.3 APAC Low Dosage Hydrate Inhibitors (LDHI) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Low Dosage Hydrate Inhibitors (LDHI) by Country
7.1.1 Europe Low Dosage Hydrate Inhibitors (LDHI) Sales by Country (2018-2023)
7.1.2 Europe Low Dosage Hydrate Inhibitors (LDHI) Revenue by Country (2018-2023)
7.2 Europe Low Dosage Hydrate Inhibitors (LDHI) Sales by Type
7.3 Europe Low Dosage Hydrate Inhibitors (LDHI) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) by Country
8.1.1 Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Revenue by Country (2018-2023)
8.2 Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales by Type
8.3 Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Low Dosage Hydrate Inhibitors (LDHI)
10.3 Manufacturing Process Analysis of Low Dosage Hydrate Inhibitors (LDHI)
10.4 Industry Chain Structure of Low Dosage Hydrate Inhibitors (LDHI)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Low Dosage Hydrate Inhibitors (LDHI) Distributors
11.3 Low Dosage Hydrate Inhibitors (LDHI) Customer
12 World Forecast Review for Low Dosage Hydrate Inhibitors (LDHI) by Geographic Region
12.1 Global Low Dosage Hydrate Inhibitors (LDHI) Market Size Forecast by Region
12.1.1 Global Low Dosage Hydrate Inhibitors (LDHI) Forecast by Region (2024-2029)
12.1.2 Global Low Dosage Hydrate Inhibitors (LDHI) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Low Dosage Hydrate Inhibitors (LDHI) Forecast by Type
12.7 Global Low Dosage Hydrate Inhibitors (LDHI) Forecast by Application
13 Key Players Analysis
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.1.3 BASF Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 Schlumberger
13.2.1 Schlumberger Company Information
13.2.2 Schlumberger Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.2.3 Schlumberger Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Schlumberger Main Business Overview
13.2.5 Schlumberger Latest Developments
13.3 Arkema
13.3.1 Arkema Company Information
13.3.2 Arkema Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.3.3 Arkema Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Arkema Main Business Overview
13.3.5 Arkema Latest Developments
13.4 Ashland
13.4.1 Ashland Company Information
13.4.2 Ashland Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.4.3 Ashland Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ashland Main Business Overview
13.4.5 Ashland Latest Developments
13.5 ERO CHEM LLC
13.5.1 ERO CHEM LLC Company Information
13.5.2 ERO CHEM LLC Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.5.3 ERO CHEM LLC Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 ERO CHEM LLC Main Business Overview
13.5.5 ERO CHEM LLC Latest Developments
13.6 Halliburton
13.6.1 Halliburton Company Information
13.6.2 Halliburton Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.6.3 Halliburton Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Halliburton Main Business Overview
13.6.5 Halliburton Latest Developments
13.7 GE(Baker Hughes)
13.7.1 GE(Baker Hughes) Company Information
13.7.2 GE(Baker Hughes) Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.7.3 GE(Baker Hughes) Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 GE(Baker Hughes) Main Business Overview
13.7.5 GE(Baker Hughes) Latest Developments
13.8 Clariant Chemicals
13.8.1 Clariant Chemicals Company Information
13.8.2 Clariant Chemicals Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.8.3 Clariant Chemicals Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Clariant Chemicals Main Business Overview
13.8.5 Clariant Chemicals Latest Developments
13.9 Ecolab
13.9.1 Ecolab Company Information
13.9.2 Ecolab Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.9.3 Ecolab Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ecolab Main Business Overview
13.9.5 Ecolab Latest Developments
13.10 GasHydrate LLC
13.10.1 GasHydrate LLC Company Information
13.10.2 GasHydrate LLC Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
13.10.3 GasHydrate LLC Low Dosage Hydrate Inhibitors (LDHI) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GasHydrate LLC Main Business Overview
13.10.5 GasHydrate LLC Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Low Dosage Hydrate Inhibitors (LDHI) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Low Dosage Hydrate Inhibitors (LDHI) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Anti-Agglomerate (AA) Inhibitors
Table 4. Major Players of Kinetic Hydrate Inhibitors (KHI)
Table 5. Major Players of Others
Table 6. Global Low Dosage Hydrate Inhibitors (LDHI) Sales by Type (2018-2023) & (K MT)
Table 7. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Type (2018-2023)
Table 8. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue by Type (2018-2023) & ($ million)
Table 9. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Type (2018-2023)
Table 10. Global Low Dosage Hydrate Inhibitors (LDHI) Sale Price by Type (2018-2023) & (USD/MT)
Table 11. Global Low Dosage Hydrate Inhibitors (LDHI) Sales by Application (2018-2023) & (K MT)
Table 12. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Application (2018-2023)
Table 13. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue by Application (2018-2023)
Table 14. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Application (2018-2023)
Table 15. Global Low Dosage Hydrate Inhibitors (LDHI) Sale Price by Application (2018-2023) & (USD/MT)
Table 16. Global Low Dosage Hydrate Inhibitors (LDHI) Sales by Company (2018-2023) & (K MT)
Table 17. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Company (2018-2023)
Table 18. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Company (2018-2023)
Table 20. Global Low Dosage Hydrate Inhibitors (LDHI) Sale Price by Company (2018-2023) & (USD/MT)
Table 21. Key Manufacturers Low Dosage Hydrate Inhibitors (LDHI) Producing Area Distribution and Sales Area
Table 22. Players Low Dosage Hydrate Inhibitors (LDHI) Products Offered
Table 23. Low Dosage Hydrate Inhibitors (LDHI) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Low Dosage Hydrate Inhibitors (LDHI) Sales by Geographic Region (2018-2023) & (K MT)
Table 27. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share Geographic Region (2018-2023)
Table 28. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Low Dosage Hydrate Inhibitors (LDHI) Sales by Country/Region (2018-2023) & (K MT)
Table 31. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Country/Region (2018-2023)
Table 32. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales by Country (2018-2023) & (K MT)
Table 35. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Country (2018-2023)
Table 36. Americas Low Dosage Hydrate Inhibitors (LDHI) Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Country (2018-2023)
Table 38. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales by Type (2018-2023) & (K MT)
Table 39. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales by Application (2018-2023) & (K MT)
Table 40. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales by Region (2018-2023) & (K MT)
Table 41. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Region (2018-2023)
Table 42. APAC Low Dosage Hydrate Inhibitors (LDHI) Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Region (2018-2023)
Table 44. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales by Type (2018-2023) & (K MT)
Table 45. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales by Application (2018-2023) & (K MT)
Table 46. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales by Country (2018-2023) & (K MT)
Table 47. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Country (2018-2023)
Table 48. Europe Low Dosage Hydrate Inhibitors (LDHI) Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Country (2018-2023)
Table 50. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales by Type (2018-2023) & (K MT)
Table 51. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales by Application (2018-2023) & (K MT)
Table 52. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales by Country (2018-2023) & (K MT)
Table 53. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales by Type (2018-2023) & (K MT)
Table 57. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales by Application (2018-2023) & (K MT)
Table 58. Key Market Drivers & Growth Opportunities of Low Dosage Hydrate Inhibitors (LDHI)
Table 59. Key Market Challenges & Risks of Low Dosage Hydrate Inhibitors (LDHI)
Table 60. Key Industry Trends of Low Dosage Hydrate Inhibitors (LDHI)
Table 61. Low Dosage Hydrate Inhibitors (LDHI) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Low Dosage Hydrate Inhibitors (LDHI) Distributors List
Table 64. Low Dosage Hydrate Inhibitors (LDHI) Customer List
Table 65. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Forecast by Region (2024-2029) & (K MT)
Table 66. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales Forecast by Country (2024-2029) & (K MT)
Table 68. Americas Low Dosage Hydrate Inhibitors (LDHI) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales Forecast by Region (2024-2029) & (K MT)
Table 70. APAC Low Dosage Hydrate Inhibitors (LDHI) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales Forecast by Country (2024-2029) & (K MT)
Table 72. Europe Low Dosage Hydrate Inhibitors (LDHI) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Forecast by Type (2024-2029) & (K MT)
Table 76. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Forecast by Application (2024-2029) & (K MT)
Table 78. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. BASF Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 80. BASF Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 81. BASF Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. BASF Main Business
Table 83. BASF Latest Developments
Table 84. Schlumberger Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 85. Schlumberger Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 86. Schlumberger Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Schlumberger Main Business
Table 88. Schlumberger Latest Developments
Table 89. Arkema Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 90. Arkema Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 91. Arkema Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Arkema Main Business
Table 93. Arkema Latest Developments
Table 94. Ashland Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 95. Ashland Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 96. Ashland Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Ashland Main Business
Table 98. Ashland Latest Developments
Table 99. ERO CHEM LLC Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 100. ERO CHEM LLC Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 101. ERO CHEM LLC Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. ERO CHEM LLC Main Business
Table 103. ERO CHEM LLC Latest Developments
Table 104. Halliburton Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 105. Halliburton Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 106. Halliburton Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Halliburton Main Business
Table 108. Halliburton Latest Developments
Table 109. GE(Baker Hughes) Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 110. GE(Baker Hughes) Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 111. GE(Baker Hughes) Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. GE(Baker Hughes) Main Business
Table 113. GE(Baker Hughes) Latest Developments
Table 114. Clariant Chemicals Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 115. Clariant Chemicals Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 116. Clariant Chemicals Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Clariant Chemicals Main Business
Table 118. Clariant Chemicals Latest Developments
Table 119. Ecolab Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 120. Ecolab Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 121. Ecolab Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Ecolab Main Business
Table 123. Ecolab Latest Developments
Table 124. GasHydrate LLC Basic Information, Low Dosage Hydrate Inhibitors (LDHI) Manufacturing Base, Sales Area and Its Competitors
Table 125. GasHydrate LLC Low Dosage Hydrate Inhibitors (LDHI) Product Portfolios and Specifications
Table 126. GasHydrate LLC Low Dosage Hydrate Inhibitors (LDHI) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. GasHydrate LLC Main Business
Table 128. GasHydrate LLC Latest Developments
List of Figures
Figure 1. Picture of Low Dosage Hydrate Inhibitors (LDHI)
Figure 2. Low Dosage Hydrate Inhibitors (LDHI) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Low Dosage Hydrate Inhibitors (LDHI) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Anti-Agglomerate (AA) Inhibitors
Figure 10. Product Picture of Kinetic Hydrate Inhibitors (KHI)
Figure 11. Product Picture of Others
Figure 12. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Type in 2022
Figure 13. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Type (2018-2023)
Figure 14. Low Dosage Hydrate Inhibitors (LDHI) Consumed in Onshore
Figure 15. Global Low Dosage Hydrate Inhibitors (LDHI) Market: Onshore (2018-2023) & (K MT)
Figure 16. Low Dosage Hydrate Inhibitors (LDHI) Consumed in Offshore
Figure 17. Global Low Dosage Hydrate Inhibitors (LDHI) Market: Offshore (2018-2023) & (K MT)
Figure 18. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Application (2022)
Figure 19. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Application in 2022
Figure 20. Low Dosage Hydrate Inhibitors (LDHI) Sales Market by Company in 2022 (K MT)
Figure 21. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Company in 2022
Figure 22. Low Dosage Hydrate Inhibitors (LDHI) Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Company in 2022
Figure 24. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales 2018-2023 (K MT)
Figure 27. Americas Low Dosage Hydrate Inhibitors (LDHI) Revenue 2018-2023 ($ Millions)
Figure 28. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales 2018-2023 (K MT)
Figure 29. APAC Low Dosage Hydrate Inhibitors (LDHI) Revenue 2018-2023 ($ Millions)
Figure 30. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales 2018-2023 (K MT)
Figure 31. Europe Low Dosage Hydrate Inhibitors (LDHI) Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales 2018-2023 (K MT)
Figure 33. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Revenue 2018-2023 ($ Millions)
Figure 34. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Country in 2022
Figure 35. Americas Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Country in 2022
Figure 36. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Type (2018-2023)
Figure 37. Americas Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Application (2018-2023)
Figure 38. United States Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Region in 2022
Figure 43. APAC Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Regions in 2022
Figure 44. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Type (2018-2023)
Figure 45. APAC Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Application (2018-2023)
Figure 46. China Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Country in 2022
Figure 54. Europe Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Country in 2022
Figure 55. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Type (2018-2023)
Figure 56. Europe Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Application (2018-2023)
Figure 57. Germany Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share by Application (2018-2023)
Figure 66. Egypt Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Low Dosage Hydrate Inhibitors (LDHI) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Low Dosage Hydrate Inhibitors (LDHI) in 2022
Figure 72. Manufacturing Process Analysis of Low Dosage Hydrate Inhibitors (LDHI)
Figure 73. Industry Chain Structure of Low Dosage Hydrate Inhibitors (LDHI)
Figure 74. Channels of Distribution
Figure 75. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Forecast by Region (2024-2029)
Figure 76. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Low Dosage Hydrate Inhibitors (LDHI) Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Low Dosage Hydrate Inhibitors (LDHI) Revenue Market Share Forecast by Application (2024-2029)

※参考情報

低用量水と物阻害剤（Low Dosage Hydrate Inhibitors、LDHI）は、油田や天然ガスの産出技術において重要な役割を果たしています。これらの化学物質は、核水や天然ガスの輸送過程で形成される水和物（ハイドレート）を抑制するために使用されます。水和物は水分子がガス分子と結びついてできる固体の結晶構造で、パイプライン内で堆積すると流体の移動を妨げ、生産プラントを運用する上で深刻な問題を引き起こします。LDHIは、これらの水和物の形成を防ぐために開発された化学薬品であり、その名前が示す通り低用量で効果を発揮することが特徴です。

LDHIの主な定義としては、天然ガスや石油の採掘・輸送における水和物の生成を抑えるための化学物質であり、通常の防止剤に比べて使用する量が少ないことが挙げられます。これによりコスト削減や環境負荷の軽減が期待されます。LDHIは一般的に数ppm（parts per million）の濃度で効果を持つため、この特性が商業的にも採用される理由となっています。

LDHIの特徴には、まずその低用量性があります。従来の水和物防止剂は高濃度で使用されることが多く、コストや環境への影響が懸念される点がありましたが、LDHIはその必要がなく、関与する化学物質が少量で済むため、コスト効率が向上します。また、環境に対しても優しい物質が多く、持続可能な開発を支持する技術であるといえます。

LDHIの種類には主に二つのカテゴリがあります。一つは「物理的LDHI」であり、これらは水和物の形成を物理的に抑制するもので、水和物が形成される際の条件を変化させることでその生成を防ぎます。もう一つは、化学的LDHIです。このタイプは水和物の核生成を抑えることで、その結晶構造を形成させないように作用します。具体的には、界面活性剤やポリマー、特定の低分子の化合物が含まれます。

LDHIはさまざまな用途に利用されます。主な用途としては、石油および天然ガスの採掘・輸送であり、これによりパイプラインでの水和物問題を防ぎます。特に北海やアラスカなど寒冷地域においては、水和物の形成が頻繁に見られるため、LDHIの需要が高まります。また、LDHIはオフショア施設や地熱エネルギー、さらには化学プロセスでも利用されることがあります。

LDHIの関連技術としては、ハイドレートの形成メカニズムや、LDHIの評価手法、さらには新しいLDHIの研究開発が挙げられます。近年では、AIや機械学習を活用した新しいLDHIの設計も試みられており、これによりより効率的かつ効果的な防止剤の開発が期待されています。また、ナノテクノロジーを利用した新素材の開発も進んでおり、LDHIの性能向上にも寄与すると考えられています。

LDHIの市場は年々成長しており、世界中の石油・ガス産業において需要が高まっています。これは、液体の流動性を向上させることでパイプラインの効率を最大化し、コストを削減するために欠かせない存在となっているからです。今後、持続可能な開発の観点からも、環境負荷を軽減する技術としてのLDHIの役割はますます重要性を増すと予想されます。そのため、研究機関や企業が共同でさまざまな技術を開発し、最適なLDHIを追求する動きが盛んです。

LDHIの利点と欠点を理解し、それを適切に利用することが、今後の石油・ガス産業における競争力を左右する重要な要素となるでしょう。特に、持続可能なエネルギーの需要が高まる中で、LDHIはその技術的な革新とともに、将来的に重要な役割を果たすこととなるでしょう。したがって、LDHIに関する研究は今後ますます進展していくことが期待されます。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の低用量水和物阻害剤（LDHI）市場予測 2023年-2029年(Global Low Dosage Hydrate Inhibitors (LDHI) Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の低用量水和物阻害剤市場予測 2023年-2029年
  • ハイドレート阻害剤の世界市場（〜2030）
  • 世界のアトロピン硫酸塩水和物API市場予測 2023年-2029年
  • 世界のエスクリン水和物市場予測 2023年-2029年
  • 世界のアトロピン硫酸塩水和物試薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆